<DOC>
	<DOC>NCT00345371</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of topiramate as compared to placebo in reducing methamphetamine use in subjects with methamphetamine dependence.</brief_summary>
	<brief_title>Topiramate for the Treatment of Methamphetamine Dependence - 1</brief_title>
	<detailed_description />
	<mesh_term>Methamphetamine</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Treatment seeking individuals as the time of the study Must be able to proved written informed consent Must have a body mass index greater than 18 kg/m(2) Must meet DSMIV criteria for methamphetamine dependence Must currently be using methamphetamine as confirmed by a positive urine test over the past 14 days If female of child bearing potential, must agree to use birth control Please contact the site for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>methamphetamine addiction</keyword>
</DOC>